- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
13 result(s) found for: Asymptomatic bacteriuria.
Displaying page 1 of 1.
EudraCT Number: 2012-003857-26 | Sponsor Protocol Number: BIRT | Start Date*: 2013-12-11 |
Sponsor Name:ULB ERASME HOSPITAL | ||
Full Title: The Bacteriuria In Renal Transplantation study: A prospective, randomized, multicenter trial comparing antibiotics versus no treatment in the prevention of urinary tract infection in kidney transpl... | ||
Medical condition: Asymptomatic bacteriuria after renal transplantation. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001108-47 | Sponsor Protocol Number: BARIFER | Start Date*: 2016-05-29 |
Sponsor Name:Fundació Hospital Universitari Vall Hebron-Institut de Recerca (VHIR) | ||
Full Title: Impact of eradication of asymptomatic bacteriuria on reducing the incidence of early infection in patients with periprosthetic femoral fractures requiring hip hemiarthroplasty | ||
Medical condition: Early infection in patients with periprosthetic femoral fracture | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001716-30 | Sponsor Protocol Number: BAC01 | Start Date*: 2012-09-27 | ||||||||||||||||
Sponsor Name:Hospital Universitari de Bellvitge | ||||||||||||||||||
Full Title: Randomized, prospective trial comparing antibiotic treatment to observation in renal transplant patients with asimptomatic bacteriuria | ||||||||||||||||||
Medical condition: Asyntomatic bacteriuria an acute pyelonephritis in renal transplant patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000129-61 | Sponsor Protocol Number: ASB-treat-study | Start Date*: 2011-11-14 | |||||||||||
Sponsor Name:AMC Amsterdam | |||||||||||||
Full Title: ASB treat study: Preventing preterm birth with nitrofurantoin: Costs and effects of screening and treating healthy women for asymptomatic bacteriuria’ | |||||||||||||
Medical condition: Preterm birth<34wks and pyelonefritis in singleton healthy pregnancies | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001481-42 | Sponsor Protocol Number: ITFE-2026-C11 | Start Date*: 2018-10-04 | |||||||||||
Sponsor Name:ITF RESEARCH PHARMA S.L.U. | |||||||||||||
Full Title: Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a 0.005% estriol vaginal gel in the prevention of recurrent urinary tract infection... | |||||||||||||
Medical condition: Recurrent Urinary Tract Infection (UTI) in postmenopausal women with vaginal atrophy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001031-31 | Sponsor Protocol Number: BIPROST | Start Date*: 2012-06-04 |
Sponsor Name:Fundación para Formación e Investigación Sanitaria | ||
Full Title: Randomized controlled trial of the efficacy of fosfomycin vs ciprofloxacin as antibiotic prophylaxis before transrectal ultrasound guided prostate | ||
Medical condition: urinary sepsis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000259-35 | Sponsor Protocol Number: 2020_03 | Start Date*: 2022-04-29 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Lille | |||||||||||||
Full Title: Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoing intra-vesical botulinum toxin A injections | |||||||||||||
Medical condition: Overactive bladder (OAB) and/or detrusor overactivity (DO) in multiple sclerosis (MS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002556-32 | Sponsor Protocol Number: ANTIC:6672 | Start Date*: 2013-09-05 | |||||||||||
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Antibiotic treatment for intermittent bladder catheterisation: A randomised controlled trial of once daily prophylaxis (The AnTIC study) | |||||||||||||
Medical condition: Recurrent urinary tract infection in people who use intermittent bladder catheterisation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003487-36 | Sponsor Protocol Number: 1 | Start Date*: 2015-12-23 | |||||||||||
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women | |||||||||||||
Medical condition: Recurrent urinary tract infection in women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009216-53 | Sponsor Protocol Number: 191622-094 | Start Date*: 2009-04-04 | |||||||||||
Sponsor Name:Allergan Ltd | |||||||||||||
Full Title: A Multicenter, Long-term Follow-up Study of the Safety and Efficacy of Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Patients with Urinary Incontinence Due to Ne... | |||||||||||||
Medical condition: Urinary incontinence due to neurogenic detrusor overactivity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) NL (Completed) GB (Completed) FR (Completed) DE (Completed) IT (Completed) ES (Completed) BE (Completed) AT (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002143-83 | Sponsor Protocol Number: 191622-515 | Start Date*: 2006-07-25 | |||||||||||
Sponsor Name:Allergan Ltd | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified N... | |||||||||||||
Medical condition: Urinary Incontinence Due to Neurogenic Detrusor Overactivity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) AT (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003407-12 | Sponsor Protocol Number: 191622-518 | Start Date*: 2008-02-19 | |||||||||||
Sponsor Name:Allergan Limited | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Explore the Dose Dependent Response to Three Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin ... | |||||||||||||
Medical condition: Neurogenic detrusor overactivity as a result of spinal cord injury, in patients with urinary incontinence, who have not been adequately managed with anticholinergic therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000192-42 | Sponsor Protocol Number: 191622-516 | Start Date*: 2007-07-25 | |||||||||||
Sponsor Name:Allergan Ltd | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of a Single Treatment with Two Dose Levels of BOTOX® (Botulinum Toxin Type A) Purified N... | |||||||||||||
Medical condition: Urinary incontinence due to neurogenic detrusor overactivity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) NL (Completed) PT (Completed) ES (Completed) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
